A

Agenus

D
AGEN
USD
-0.255
(-8.4158%)
Market Closed
19,747.00
حجم التداول
-8.34
الربح لكل سهم
-
العائد الربحي
-0.249102
P/E
59,862,136.28
حجم السوق
اليوم
-8.4158%
1 اسبوع
-29.569%
1 شهر
-41.270%
6 اشهر
-74.041%
12 اشهر
-81.014%
بداية السنة
-83.263%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Agenus

Sector:
Healthcare
Industry:
Biotechnology
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
هل تحتاج مساعدة او لديك استفسار؟